Lobbying client
BIOVERATIV INC.
Biopharmaceutical development
Filings
8
Filed by
1
Reported in-house
—
Reported by firms
$220,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2017 to 2019
Filings
8 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination (No Activity) 1st Quarter 2019
|
AVENUE SOLUTIONS | $40,000 reported |
|
4th Quarter - Report 4th Quarter 2018
|
AVENUE SOLUTIONS | $40,000 reported |
|
3rd Quarter - Report 3rd Quarter 2018
|
AVENUE SOLUTIONS | $40,000 reported |
|
2nd Quarter - Report 2nd Quarter 2018
|
AVENUE SOLUTIONS | $40,000 reported |
|
1st Quarter - Report 1st Quarter 2018
|
AVENUE SOLUTIONS | $40,000 reported |
|
4th Quarter - Report 4th Quarter 2017
|
AVENUE SOLUTIONS | $10,000 reported |
|
3rd Quarter - Report 3rd Quarter 2017
|
AVENUE SOLUTIONS | $10,000 reported |
|
Registration 3rd Quarter 2017
|
AVENUE SOLUTIONS | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| AVENUE SOLUTIONS | 7 | $220,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 6 |
| Trade (domestic/foreign) | TRD | 2 |
| Taxation/Internal Revenue Code | TAX | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.